Mangalam Drugs And Organics Limited has informed the Exchange about Amalgamation/Merger
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs And Organics Limited has informed the stock exchange about an amalgamation or merger plan. The company has disclosed the development under its listing obligations. Specific details on the merger counterparty, share swap ratio, and the stage of approval (board vs. NCLT) are not included in the headline and need to be checked in the full filing. The announcement signals a corporate restructuring event that could reshape the company's size and business profile. Investors should review the full scheme document for valuation, swap ratio, and timeline details.
Short-term stock price may react to the merger news depending on the swap ratio and the acquirer's identity. Shareholders should watch for the detailed scheme of arrangement and NCLT approval timelines before assessing long-term value impact.